Global Cardiac Monitoring Market Industry Market Size - Share Outlook, Growth Analysis Report and Forecast Trends 2026-2030

The cardiac monitoring market covers diagnostic and surveillance tools that record, analyze, and report on cardiac electrical activity for clinical decision-making. The global market was valued at approximately USD 23.14 billion in 2025 and is projected to expand at a CAGR of 6.34%, reaching roughly USD 31 billion by 2030 based on that trajectory. Independent public estimates of the same market vary widely depending on scope, ranging from about USD 10 billion to over USD 40 billion in 2025, reflecting differences in how broader rhythm management and diagnostic device categories are included.

• •Core device categories include resting ECG, Holter monitors, event monitors, implantable loop recorders, and mobile cardiac telemetry.
• •Heterogeneous scope across reports is the main reason published 2025 valuations span roughly USD 10 billion to USD 41 billion.
• •Hospitals, ambulatory care, and home-based monitoring represent the principal end-use settings.

Rising global prevalence of cardiovascular disease, atrial fibrillation, and heart failure is the principal clinical driver, alongside population aging across North America, Europe, and parts of Asia. The expansion of telehealth reimbursement frameworks and growing physician acceptance of remote patient monitoring are accelerating device adoption outside hospital settings. Technological advances such as AI-assisted arrhythmia detection, longer-lasting implantable sensors, and integration with consumer wearables are expanding the addressable patient pool.

• •Aging populations in OECD economies are increasing the incidence of chronic cardiac conditions requiring ongoing monitoring.
• •Reimbursement expansion for remote patient monitoring in the U.S. and parts of Europe is supporting prescription-based adoption.
• •AI-enabled ECG analytics are improving diagnostic yield and reducing clinician workload, encouraging broader deployment.

By product type, the market is typically segmented into ECG devices, Holter and event monitors, implantable cardiac monitors, and mobile cardiac telemetry, with mobile telemetry and implantable devices representing the fastest-growing sub-segments. By end user, hospitals hold the largest share, while ambulatory and home-based monitoring are growing most rapidly due to decentralization of care. Geographically, North America leads in revenue share, followed by Europe, while Asia-Pacific is the fastest-growing region driven by healthcare investment in China, India, and Japan.

• •North America accounts for the largest share of global revenue, supported by established reimbursement and clinical guidelines.
• •Asia-Pacific is the fastest-growing region, with rising healthcare expenditure and large undiagnosed patient populations.
• •Mobile cardiac telemetry and implantable loop recorders are growing faster than conventional resting ECG systems.

What are the recent trends and outlook?

The most consequential trend is the convergence of consumer wearables and clinical-grade cardiac monitoring, with smartwatches and patches increasingly used as referral pathways into formal diagnostic workflows. AI and cloud-based analytics platforms are becoming standard differentiators, enabling earlier detection of arrhythmias and reduced time-to-diagnosis. Over the medium term, sustained growth at around 6% annually is expected, with value creation shifting toward software-enabled monitoring services and integrated care pathways.

• •Consumer wearable data is increasingly being integrated into clinical decision pathways for atrial fibrillation screening.
• •AI-driven ECG interpretation is reducing manual review burden and supporting scaling of remote monitoring programs.
• •Reimbursement for remote cardiac monitoring services is expected to remain a critical determinant of adoption pace.